Lyfebulb-Helsinn Innovation Summit & Award in Oncology

MONTE-CARLO BAY HOTEL & RESORT, MONACO
MARCH 26-27, 2018

CHALLENGE TIMELINE

MARCH 26-27, 2018
Innovation Challenge
MARCH 27, 2018
Winner Announcement

The Winner

GreenBone Ortho srl

Lorenzo is the Co-Founder & CEO of GreenBone Ortho srl, a startup founded in 2014 to develop a highly innovative wood-derived, biomimetic and re-absorbable bone implants to repair critical defects in load load bearing and non-loaded bones. Lorenzo has a background in Pharmacology and Business in Innovation, with more than 25 years experiences in R&D, Business Development and Venture Capital. He held various senior positions in multinational companies such as Zambon Group SpA and Cardinal Health Inc. General Manager of Zcube srl (Research Venture of Zambon Group) from 2008, Lorenzo established collaborations and investments with major universities hubs in Europe, United States and Israel, as well as with Mission Bay Capital and the California Institute for Quantitative Biosciences (QB3), headquartered on the UCSF Mission Bay campus. Board member of biotech start-ups, including SuppreMol GmbH acquired by Baxter International Inc. in 2015. President of Italy HealthCare Licensing Group (Italy HLG) 2010-2014.

Lorenzo Pradella, PhD
Co-Founder and CEO

LYFEBULB-HELSINN
INNOVATION SUMMIT &
AWARD IN ONCOLOGY

Eleven innovators will compete at the Lyfebulb-Helsinn Investment Fund Innovation Summit for the first ever Lyfebulb-Helsinn Investment Fund Innovation Award, which will be presented to an exceptional innovator with outstanding entrepreneurial potential to commercialize creative efforts and ideas to better manage cancer using drugs, medical devices, or consumer products, and healthcare information technologies

THE AWARD
One innovator will be awarded the first Lyfebulb-Helsinn Investment Fund Innovation Award in cancer treatment and cancer supportive care
lyfebulb helsinn 2018 – oncology awards

ABOUT THE AWARD

Monetary grants up to $25K will be awarded to the winners, as well as the opportunity for all finalists to be in a position to be better noticed by venture capital funds

BENEFITS OF THE LYFEBULB-HELSINN INVESTMENT FUND INNOVATION SUMMIT & AWARD

National and international recognition. The benefit for innovators of participating is
the visibility given to the selected 10 finalists, and the Winner in particular

Invitation to the Lyfebulb–Helsinn Innovation Summit 2018 in Monaco as one of 10 Finalists.
The Innovation Summit aims to link innovators with senior leadership from Lyfebulb and Helsinn in order
to spotlight innovators’ efforts and ideas, and provide professional discussion, direction, and inspiration.

The winner will be chosen on March 27, 2018 by a prestigious, international panel.

THE SUMMIT
At this Summit, 10 selected Innovators will compete for
monetary grants and be given the opportunity to be considered for a
possible investment by the Helsinn Investment Fund

ABOUT THE SUMMIT

Beyond presenting their innovative ventures to this group, the 10 finalists will also have a chance to interact and exchange ideas on how to advance further patient innovatorship in the cancer community, engage with Lyfebulb founders, Helsinn Investment Fund leadership, representatives from the patient community, key opinion leaders, and potential investors and compete for a monetary grant.

The Lyfebulb-Helsinn Investment Fund Innovation Summit stems from the idea of the Lyfebulb Entrepreneur Circle, established in 2015, and features people who have created a product and a company based on issues encountered because of their personal experiences with a chronic illness.

Patient innovators have a unique ability to create a value-adding disease intervention beyond therapy. Our aim is to support patient-driven innovation and we are laser-focused on improving the quality of life for those living with cancer.

SHARE

FINALISTS

JUDGES

Carolyn R. “Bo” Aldigé

President and Founder at Prevent Cancer Foundation

Professor Franco Cavalli, MD

Director of Oncology at Oncology Institute of Southern Switzerland

Dr. Françoise Meunier, MD, PhD, FRCP

Director of Special Projects at EORTC

Professor Patrick Rampal, MD

President at Scientific Center of Monaco

Stephen Squinto, PhD

Co-Founder & Chairman at Lyfebulb, Venture Partner at Orbimed and Co-Founder at Alexion at Orbimed and Alexion